1.
Res Sq
; 2023 Apr 04.
Article
in English
| MEDLINE | ID: covidwho-2312478
ABSTRACT
A 44-year-old female patient with multiple sclerosis (MS) treated with ocrelizumab was hospitalized with SARS-CoV-2 pneumonia three times over the course of five months, eventually expiring. Viral sequencing of samples from her first and last admissions suggests a single persistent SARS-CoV-2 infection. We hypothesize that her immunocompromised state, due to MS treatment with an immunosuppressive monoclonal antibody, prevented her from achieving viral clearance.
2.
J Cardiothorac Vasc Anesth
; 36(12): 4553-4555, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-2008343